This press release contains:
--Summaries of newsworthy articles:
~Science of Health: The Ethnic Health Advantage
~Science Agenda: Ban Chimp Testing
The full articles highlighted below are available on the Nature Press Site: http://press.nature.com/press.
------------------------------------------------------------------------------
Science of Health: The Ethnic Health Advantage (p 30)
Two populations in the US tend to outlive their often richer neighbours, and Laura Blue explains why in this month’s Scientific American Science of Health column. Her work points to one lifestyle factor: smoking.
All other things being equal, people with greater income or formal education in the U.S. tend to live longer and enjoy better health than their counterparts who make less money or have not attended school for as long. Health researchers have long been puzzled by two notable exceptions to these trends. Immigrants from most nations apparently live longer than their native born neighbors in the U.S. In addition, people of Hispanic descent in the U.S. seem to live longer than non-Hispanic whites, who are, on average, richer and better educated.
Blue set out to test whether something as obvious as smoking could explain the immigrants’ and Hispanics’ life expectancy advantage in the U.S. She and her research partner used death from lung cancer as their metric of a smoking related death since over 80% of deaths from the disease are caused by smoking. The team do not measure smoking habits here, but previous work has suggested non-foreign-born Hispanics smoke substantially less than their US-born counterparts. Their results suggest that in the year 2000 smoking explained more than 75% of the difference in life expectancy at age 50 between Hispanic and non-Hispanic white men and around 75% in women.
Health information is improving in the U.S. and smoking rates are decreasing, but the opposite effect is true in the developing world. “I expect that both the immigrant advantage and the Hispanic paradox may disappear within the next few decades,” concludes the author.
Author contact:
Editors at Scientific American are available to comment on this topic; please contact the Press Office
E-mail: [email protected]
------------------------------------------------------------------------------
Science Agenda: Ban Chimp Testing (p 12)
It is time to phase out invasive biomedical experimentation on chimpanzees, argue the editors of Scientific American in this month’s Science Agenda column. Though testing on chimps has provided us with incredible boon of knowledge—contributing to the discovery of vaccines for polio and hepatitis B—now there are alternatives.
Evolutionarily, chimps are our closest living relatives and similar to humans, they show a capacity for fear, anxiety, grief, and depression. The ethical and moral issues that arise from utilizing chimps in experiments are acute. Yet, the NIH seems to be moving in the wrong direction when it recently announced that 180 chimps that were in a biomedical retirement facility would soon rejoin the roughly 800 other chimps that are part of human disease, therapy, and vaccine studies.
The editors recognize that the tradeoffs are difficult to weight and that some may still see a need for invasive testing on chimps to develop crucial therapies. However, they write: “If the U.S. elects to continue testing on chimps, then it needs to adopt stricter guidelines.” The U.S. Department of Agriculture, which presently enforces the Animal Welfare Act, needs to establish a committee of scientists, bioethicists, and representatives from animal welfare groups specifically aimed at the ethics of biomedical research on chimps. It is imperative that in the pursuit of solving human diseases, we minimize the harm we cause.
Author contact:
Editors at Scientific American are available to comment on this topic; please contact the Press Office
E-mail: [email protected]
PRESS CONTACTS…
From North America and Canada
Neda Afsarmanesh, Nature New York
Tel: +1 212 726 9231; E-mail: [email protected]
From the UK/Europe/other countries not listed above
Ruth Francis, Nature London
Tel: +44 20 7843 4562; E-mail [email protected]
From Japan, Korea, China, Singapore and Taiwan
Mika Nakano, Nature Tokyo
Tel: +81 3 3267 8751; E-mail: [email protected]
------------------------------------------------------------------------------
About Nature Publishing Group (NPG):
Nature Publishing Group (NPG) is a publisher of high impact scientific and medical information in print and online. NPG publishes journals, online databases and services across the life, physical, chemical and applied sciences and clinical medicine.
Focusing on the needs of scientists, Nature (founded in 1869) is the leading weekly, international scientific journal. In addition, for this audience, NPG publishes a range of Nature research journals and Nature Reviews journals, plus a range of prestigious academic journals including society-owned publications. Online, nature.com provides over 5 million visitors per month with access to NPG publications and online databases and services, including Nature News and NatureJobs plus access to Nature Network and Nature Education’s Scitable.com.
Scientific American is at the heart of NPG’s newly-formed consumer media division, meeting the needs of the general public. Founded in 1845, Scientific American is the oldest continuously published magazine in the US and the leading authoritative publication for science in the general media. Together with scientificamerican.com and 15 local language editions around the world it reaches over 3 million consumers and scientists. Other titles include Scientific American Mind and Spektrum der Wissenschaft in Germany.
Throughout all its businesses NPG is dedicated to serving the scientific and medical communities and the wider scientifically interested general public. Part of Macmillan Publishers Limited, NPG is a global company with principal offices in London, New York and Tokyo, and offices in cities worldwide including Boston, Buenos Aires, Delhi, Hong Kong, Madrid, Barcelona, Munich, Heidelberg, Basingstoke, Melbourne, Paris, San Francisco, Seoul and Washington DC. For more information, please go to www.nature.com.
